• Bradykinin as an Endothelium-Dependent Vasodilator: Applied

  2026-07-24

  Bradykinin unlocks advanced experimental control over vascular permeability and inflammation, supporting high-precision cardiovascular and pain mechanism studies. This article delivers in-depth workflow guidance, troubleshooting tips, and protocol parameters for maximizing reproducibility with APExBIO’s Bradykinin research-grade peptide.

• Vorinostat in Translational Oncology: Mechanisms & Strategie

  2026-07-24

  This thought-leadership article unifies the mechanistic foundations of Vorinostat (suberoylanilide hydroxamic acid) as an HDAC inhibitor with actionable protocol guidance and new insights into apoptosis signaling. Drawing on recent discoveries in RNA Pol II-regulated cell death and benchmarking Vorinostat’s translational relevance, we offer strategic advice for researchers navigating the evolving landscape of epigenetic modulation and apoptosis assays in cancer biology.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Precision for

  2026-07-23

  The HyperScribe SP6 High Yield RNA Synthesis Kit empowers cutting-edge RNA research through robust, high-yield synthesis—enabling advanced probe design, RNA vaccine studies, and immune pathway interrogation. Its exceptional yield, flexibility for RNA modification, and streamlined protocol make it an indispensable tool for researchers tackling complex virology and innate immunity questions.

• 2-D08: A Selective Inhibitor of Protein Sumoylation in Resea

  2026-07-23

  2-D08 (2’,3’,4’-trihydroxyflavone) is a potent, highly selective small molecule inhibitor of protein sumoylation, uniquely blocking SUMO transfer at the E2-substrate step. Its mechanism and solubility profile make it valuable for studying posttranslational modification in cancer research and beyond.

• GSK621: Precision AMPK Agonist for AML and Immunometabolic A

  2026-07-22

  GSK621 delivers potent, selective AMPK activation for acute myeloid leukemia and immunometabolic research, outperforming legacy agonists in both efficacy and substrate phosphorylation. This guide translates recent mechanistic insights into actionable workflows, protocol refinements, and troubleshooting strategies for reproducible metabolic pathway interrogation.

• Neuritin Modulates ER Stress-NF-κB Pathways After SAH Injury

  2026-07-22

  This study reveals that Neuritin mitigates neuroinflammation and neuronal apoptosis in early brain injury following subarachnoid hemorrhage by suppressing ER stress-related NF-κB inflammatory signaling. The findings position Neuritin as a promising mechanistic target for improving neurological outcomes after hemorrhagic stroke.

• GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in Colit

  2026-07-21

  This study identifies a metabolic gatekeeping mechanism involving the GPR35-KLF5 axis that enables intestinal epithelial cells to sense and repair mucosal damage. The findings clarify how tryptophan metabolite signaling is decoded for repair programming, offering mechanistic insight with direct implications for ulcerative colitis research using DSS-induced models.

• Rapamycin (Sirolimus): Applied mTOR Inhibition in Cell Model

  2026-07-21

  Rapamycin (Sirolimus) uniquely enables the dissection of mTORC1-driven cell fate, lipid metabolism, and apoptosis with precision. This article unpacks experimental workflows, troubleshooting insights, and strategic tips for leveraging APExBIO's Rapamycin in advanced cellular and disease model systems.

• HyperFusion™ High-Fidelity DNA Polymerase: Precision for Com

  2026-07-20

  Explore how HyperFusion high-fidelity DNA polymerase empowers robust, ultra-accurate PCR amplification—even for GC-rich or long templates—and see how its advanced design supports the most demanding genomic workflows. This article provides a nuanced, application-driven perspective for scientists seeking next-generation proofreading DNA polymerase solutions.

• AZD8055: Technical Protocols for mTOR Pathway Inhibition

  2026-07-20

  AZD8055 is a potent, selective mTOR inhibitor designed for preclinical studies requiring robust suppression of both mTORC1 and mTORC2 signaling. It is best suited for mechanistic investigations in cancer and metabolic research models and should not be used where clinical efficacy is the primary endpoint.

• Sulfachloropyridazine Modulates Microbiota in E. tenella Inf

  2026-07-19

  The reference study integrates 16S rRNA sequencing and metabolomics to reveal how sulfachlorpyridazine, ethanamizuril, and their combination alter the cecal microbiota and metabolic profiles in chickens infected with Eimeria tenella. These findings provide new insights for monitoring drug efficacy and understanding the interplay between anticoccidial agents and host microbial communities.

• KPNB1-ATF4-BNIP3 Axis Drives Mitophagy in Odontoblastic Diff

  2026-07-18

  Zhang et al. reveal that the KPNB1-ATF4-BNIP3 signaling axis orchestrates BNIP3-dependent mitophagy to promote odontoblastic differentiation of dental pulp stem cells (DPSCs). These findings clarify mitochondrial quality control mechanisms in DPSC fate decisions, offering new directions for dental tissue regeneration research.

• UHRF1, DNA Methylation, and Super-Enhancer Rewiring in Senil

  2026-07-17

  This study reveals how UHRF1-mediated DNA methylation governs super-enhancer architecture and autophagy regulation via TGM2, collectively impairing osteogenic differentiation in senile osteoporosis. Integrating multi-omics profiling, the research delineates a mechanistic axis central to age-related bone loss and highlights new targets for epigenetic intervention.

• Spatial Metabolomics Uncovers Hippocampal Lipid Shifts in PO

  2026-07-17

  This study applies spatial metabolomics to delineate lipid dysregulation in the hippocampus of rats with postoperative cognitive dysfunction (POCD) following cardiopulmonary bypass. By integrating lipid imaging, protein markers, and targeted interventions, the research reveals that modulation of serine palmitoyltransferase (SPT) activity—specifically via myriocin—can rescue hippocampal lipid homeostasis and cognitive performance.

• Aztreonam in Translational Research: Mechanisms, Assay Impac

  2026-07-16

  Discover how Aztreonam, a monocyclic β-lactam antibiotic, advances Gram-negative research through unique mechanisms and practical assay implications, informed by the latest resistance gene dynamics. This article offers a deeper perspective for experimentalists seeking evidence-based protocol decisions.

11695 records 1/780 page Next 12345 下5页 Last page